GI-102 + Eribulin

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

GI-102 + Eribulin
Treatment and conditionWhere it standsTrials
GI-102 + Eribulin for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
GI-102 + Eribulin for sarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1